Skip to main content English


Katharina Krenn Katharina Krenn

Department of Anaesthesia, Intensive Care Medicine and Pain Medicine (Division of General Anaesthesia and Intensive Care Medicine)
Position: Consultant

ORCID: 0000000269509361
T +43 1 4040041020


Acute Lung Injury; Clinical Trial; Intensive Care; Renin-Angiotensin System

Research group(s)

Research interests

My research focuses are clinical trials in critical care medicine, acute lung injury/acute respiratory distress syndrome and the renin-angiotensin-system in critical illness and the perioperative period. Currently, my research group is participating in the multicenter phase IIb trial on AP301/solnatide as inhalation therapy for ARDS.

Selected publications

  1. Krenn, K. et al., 2017. Inhaled AP301 for treatment of pulmonary edema in mechanically ventilated patients with acute respiratory distress syndrome: a phase IIa randomized placebo-controlled trial. Critical Care, 21(1). Available at:
  2. Krenn, K. et al., 2015. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans. The Journal of Thoracic and Cardiovascular Surgery, 149(4), pp.1194-1202. Available at:
  3. Krenn, K. et al., 2007. Recipient Vascular Endothelial Growth Factor Serum Levels Predict Primary Lung Graft Dysfunction. American Journal of Transplantation, 7(3), pp.700-706. Available at: